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 People with Type 2 diabetes need to change the behavior to get effective control.  
 Case management can increase the intensity of ongoing education and support. 
 The study indicates more successful glycemic control in the CM group at the end.  
 Self-care behaviors are significantly improved after case management. 
 The study indicates some improvement in empowerment ability after case 
management. 
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Abstract   
Objective  To examine the effect of case management on glycemic control and 
behavioral outcomes in adults with Type 2 diabetes in China. 
Methods  Participants were randomly assigned to a 1-year case management (CM) 
group (n=60) or control group (n=60). Monthly case management visits included 
identifying individuals’ diabetes-related problems, setting goals, planning self-care, 
and evaluating progress. During a 1-year follow-up, all participants attended visits 
every 3 months without intervention.  
Results  In the CM vs. the control group, HbA1c was reduced at 6 months 
compared to baseline (P = 0.034), with trends at 12 and 24 months, and empowerment 
ability improved (P < 0.05). Also in the CM vs. controls, total self-care behaviors, 
the frequency of exercise, blood glucose testing, and foot care were higher (P < 
0.001) at 12 months, and the percentage of individuals with HbA1c < 7.0% was 
higher (P = 0.035) at 24 months.  
Conclusion  The case management intervention in China was effective at 6 months 
and, based on trends in HbA1c at 12 and 24 months and results for behavioral 
outcomes, the intervention shows promise and warrants more research. 
Practice implications  A case management approach can enhance behavior change 
and glycemic control in Chinese with diabetes.  
 
Key words  Case management; Type 2 diabetes; blood glucose; behavior change; 
empowerment 
 
 
 
 
 
 
 
 
1. Introduction 
Diabetes mellitus is reaching epidemic proportions globally; 1.3 million deaths 
resulted from diabetes in 2010 [1]. The global prevalence of diabetes in adults is 8.3% 
(382 million people) [2]. In China, the most populous country, the prevalence of 
diabetes is high at 11.6% (affecting 113.9 million people) [3] compared to the United 
States at 9.9% [4] and Europe at 8.1% [5]. Less than one-third (30.1%) of Chinese 
diabetic patients are aware of their condition [3]. Also in China, prediabetes is 
extremely high at 50.1% (affecting 493.4 million people) [3], compared to the United 
States at 35.3% [6] and Europe at 9.6% [5]. 
Recent changes in China, including economic prosperity, environmental issues, and 
changes in life style such as poor diet with more fat and sugar have been documented 
in the Chinese literature as barriers to maintaining diabetics’ self-care regimens [7]. 
Once diagnosed, adults with diabetes in China see a physician monthly. To meet this 
demand, doctors throughout China see 50-100 patients per day. Patients undergo a 
3-10 minute outpatient visit and get their medications and diabetic supplies at the 
clinic. About 5-10% of diabetic adult outpatients at our hospital are referred to a 
certified diabetes educator because they are newly diagnosed or unable to manage 
basic care.  
Diabetes is a major risk factor for ischemic heart disease and stroke, the most 
common cause of chronic kidney disease, and a leading cause of blindness [6,8,9]. 
Improvement in glycemic control is key in preventing such complications [6]. In 
China among patients with diabetes, one-quarter receive medical treatment for 
diabetes and slightly more than one-third of patients treated for diabetes have 
adequate glycemic control [3]. Effective glycemic control cannot be assured through 
medications alone. Health promotion is essential, yet behavior change is not 
automatic [10].  
Quality care managers and nurses in China identified health care-related factors 
(such as lack of team management and ongoing support), and patient-related factors 
(such as lack of adherence by patients to regular follow-up care and to self-care) that 
lead to poor glycemic control [11]. Clearly, adults with diabetes in China need a 
long-term self-care plan [12]. One strategy that can be used by diabetes educators is 
an individually-focused case management approach in outpatient settings to increase 
the intensity of diabetic education and psychosocial support. 
The purpose of this study is to examine the effect of case management on the 
primary outcome of HbA1c and secondary outcomes of self-care behavior (diet, 
exercise, blood glucose monitoring, foot care, and medication taking) and 
empowerment ability in adults with Type 2 diabetes in China. Empowerment ability 
refers to being able to handle psychosocial adjustments related to problems caused by 
diabetes [13]. 
2. Methods 
2.1 Design and participants 
This study was a two-arm, parallel, randomized control trial examining the effect of 
case management. Participants with Type 2 diabetes were randomized to the case 
management (CM) group or the control group based on random numbers generated 
through Proc Plan (SAS9.2) and block randomization procedures with a block 
size of 4. This process was accomplished by a statistician with no clinical 
involvement in the trial, and the process was concealed from the researchers. 
Group assignment for each participant was pulled from a sequentially numbered, 
opaque, sealed and stapled envelope. Blinding was not possible. One certified 
diabetes educator executed the protocol for the CM group; another was responsible 
for the protocol in the control group. The primary outcome was HbA1c and the 
secondary outcomes were behavioral (self-care and empowerment ability). 
Participants in both groups got an equal number of study visits, to control for 
attention. Specifically, during the first 12 months, all the patients spent 15-30 
minutes at a monthly visit, only the content (presence of the intervention) was 
different between the groups. In the second year, all the patients spent 15-30 
minutes at visits every 3 months and both the content (without intervention) and 
the time were the same for the patients in the two groups.  
Study recruitment in the area surrounding one hospital in Eastern China 
occurred through flyers at community health centers, recruitment posters, and 
announcements at diabetic lectures. The study protocol was approved by the hospital 
Institutional Review Board, and the process was in accordance with the revised 
Declaration of Helsinki. Participants provided written informed consent.  
Two hundred volunteers were screened to determine eligibility. Adults with a 
diagnosis of Type 2 diabetes [7,14] for ≥ 3 months, aged 19-80 years and with ability 
to care for themselves were included. Exclusion criteria were pregnancy or concurrent 
diseases (including myocardial infarction, malignancy, serious neurological or 
psychiatric disorders, severe infections, or organ failure). Participants were enrolled in 
the study from April 2012 to February 2013. For safety purposes, each participant 
received basic diabetes education when they were enrolled. Furthermore, all 
patients received usual medical care. 
2.1.1 The case management intervention occurs in the first 12 months 
The patient-centered CM intervention was a systematic, evidence-based protocol 
focused on diabetes-related health behavior change [15]. It was individually tailored, 
initially according to the participant’s pre-existing lifestyle habits and preferences, 
and later according to answers to a standard set of questions at monthly visits. 
Teaching the participant how to use blood glucose testing data to adjust diet, exercise, 
and medication taking to achieve goals was implemented according to Chinese 
clinical guidelines [7]. 
The process of behavior change used for the CM group is presented in Fig. 1. The 
diabetes educator assessed the participant’s health care needs. Next, she discussed 
initial behavior change plans, focusing on the most important barriers to disease 
control. She gave sufficient information, suggested strategies for change, and 
answered questions to help participants (a) make decisions related to self-care or 
managing diabetes-related problems and (b) apply strategies to self-care at home. An 
individualized action plan was created by the diabetes educator and the participant. 
Goals were set for dietary changes, physical exercise, and self-monitoring.  
The diabetes educator and the participant met face-to-face monthly to assess 
difficulties toward achieving lifestyle modification goals and to detect emerging 
problems in implementing the care plan. Participants’ diabetes self-care regimens 
were evaluated with a standard set of questions: 1) How often did you go to the 
hospital to see the doctor? 2) What kind of medication do you use now? 3) Have you 
checked your blood glucose, BP, weight, HbA1c, and lipid levels? What were the 
results? 4) How often did you exercise? 5) Have you suffered from hypoglycemia this 
month? How did you deal with it? If the participant met the individualized goals, the 
diabetes educator and participant set new goals and modified the action plan. If 
participants did not, the educator helped the patient identify barriers and find 
solutions.  
The diabetes educator updated the participant’s progress monthly in the research 
record during the 12-month intervention. If necessary, participants were referred 
short-term to a doctor, a nutritionist, or psychologist who provided feedback to the 
diabetes educator through a case report form. This referral was recorded in the 
medical record. 
2.1.2 The control condition in the first 12 months 
In the control group, the diabetes educator met with the participants monthly to 
go through the same standard set of questions that was used with the CM group. The 
control group received no CM intervention. If a participant asked questions about how 
to deal with diabetes, she did not give this information and asked the participant to 
talk with his/her doctor about these questions. 
2.1.3 The follow-up from 12 to 24 months 
In the second year, neither group received an intervention. All participants visited 
with the same designated diabetes educator every three months. Both groups were 
asked the same questions as in the first 12 months, except that the time frame in the 
second year was every 3 months.  
2.2 Outcome measures 
The primary outcome measure, HbA1c, was measured by high-performance liquid 
chromatography. Self-care behavior was measured using the Chinese version of the 
Summary of Diabetes Self-care Activities (SDSCA) Scale [16], which is from a 
revised version by Toobert et al. [17]. The 11-item scale, used to measure the 
frequency of performing diabetes self-care behaviors in the last 7 days, has five 
dimensions: diet, exercise, blood glucose testing, foot care, and medication taking. 
The Cronbach’s   is 0.62, and the test–retest reliability is 0.83 [16]. In the current 
study, the Cronbach’s is 0.79. Empowerment ability was measured using the 
Chinese version of the Diabetes Empowerment Scale-Short Form (DES-SF) [18]. The 
8-item scale uses a Likert scale (not agree-always agree). The Cronbach’s   is 0.85, 
and the test–retest reliability is 0.82 [19]. In the current study, the Cronbach’s is 
0.82. 
2.3 Data collection 
Data were collected by the diabetes educators, one assigned to the CM and one 
assigned to the control group. In the first year, data on demographics and clinical 
variables from the medical record about treatment, medication use, and co-morbidities 
were obtained at baseline. In all participants, HbA1c was measured at baseline, 6, 12, 
and 24 months and self-care and empowerment ability were measured at baseline 
and12 months. 
2.4 Data analysis 
The sample size calculation considered a HbA1c reduction of 0.89% [20]
 
in the CM 
group vs. the control group with a standard deviation for HbA1c of 1.6 and a 
statistical power of 80% ( = 0.05). To this end, the study required 52 participants 
per group. A sample size of 60 participants per group (120 total) was needed in 
anticipation of a 15% dropout rate.  
For demographic variables, categorical data were analyzed using frequencies and 
percentages as well as chi-square tests; continuous data were reported as means (± 
standard deviation) and compared using the independent sample t test. For the 
primary outcome, HbA1c, a mixed model was used after adjusting for baseline 
HbA1c, treatment group, time, and the interaction of group x time; 95% 
confidence intervals of the differences are provided.  
For secondary outcomes, a paired t-test was used for within-group comparisons; 
between-group differences in the treatment effect were analyzed using an ANOVA 
test together with 95% confidence intervals. A chi-square test was used to analyze the 
HbA1c (good < 7.0% vs. poor > 7.0%) between the groups at the end of the 
follow-up period at 24 months [7]. All analysis was performed by SPSS version 16.0 
software. A two-sided P-value of 0.05 was considered statistically significant. 
3. Results 
3.1 Baseline characteristics and drop out 
 A total of 120 participants were enrolled in the study and were randomly assigned 
to the intervention group (n = 60) or the control group (n = 60). By the end of the 
study, 5 participants withdrew from the CM group and 7 participants from the control 
group (Fig. 2). The demographic characteristics and clinical valuables are presented in 
Table 1. For the overall sample, the mean age was 58.7 years, on average they had a 
normal BMI, lipid profile and blood pressure, and a mean duration of diabetes of 7.5 
years. About 96% of participants in both groups had health insurance. No difference 
was apparent in education level between groups. The two groups did not differ 
significantly at baseline (Table 1).  
3.2 Changes in glycemic control 
HbA1c at different time points is presented in Fig. 3. At baseline, there was no 
difference between the groups (7.75 ± 1.52 vs. 7.44 ± 1.66, P = 0.312). Overall, we 
did not find a statistically significant difference between the two groups through 
24 months (P = 0.6705) or an interaction of group x time (P = 0.1609), however, a 
significant time effect was observed (P = 0.0007).  
Table 2 details the changes in HbA1c from 6 to 24 months. Results shows that 
HbA1c was significantly (P = 0.034) reduced in the CM group compared to the 
control group at 6 months compared to baseline with a least mean of -0.43 (95% 
CI: -0.83,-0.03). This pattern persisted at 12 months and 24 months but did not 
achieve statistical significance (-0.32 (95% CI: -0.70, 0.06), P =0.094; -0.32 (95% 
CI: -0.79, 0.14), P =0.167, respectively.) 
Using good and poor categories for HbA1c, the percentage of participants whose 
HbA1c was good at < 7.0% was higher over time in the CM group (45.5% at baseline, 
54.5% at 6 months, 60.0% at 12 months, and 61.8% at 24 months). At the 24-month 
time point, the percentage of the participants whose HbA1c was < 7.0% was higher in 
the CM group than in the control group (61.8% vs. 41.5%, P = 0.035). 
3.3 Changes in self-care behavior and empowerment ability 
Behavioral outcomes did not differ significantly between groups at baseline. 
Self-care behavior (total, exercise, blood glucose testing, and foot care) was 
improved (P < 0.001) in the CM group vs. the control group at 12 months compared 
to baseline (Table 3). Within the CM group, self-care behavior total score as well as 
diet, exercise, foot care, and medication taking subscales were improved (P ＜ 0.05) 
between baseline and 12 months. Within the control group, blood glucose testing and 
foot care subscales were improved (P ＜ 0.05) between baseline and 12 months.  
Empowerment ability was improved (P < 0.05) in the CM group vs. the control 
group for the total score and the items about turning diabetes goals into a workable 
plan, and trying different ways to overcome barriers to attain diabetes goals at 12 
months compared to baseline. Within the CM group, empowerment ability was 
enhanced (P ＜ 0.01) for the total score and the items about dissatisfaction with parts 
of diabetes care, positive ways to cope, asking for support, and diabetes care choices 
between baseline and 12 months. Within the control group, participants’ 
empowerment ability was enhanced (P ＜ 0.05) for the total score and for items 
about dissatisfaction with parts of diabetes care and staying motivated to care for the 
diabetes between baseline and 12 months (Table 4). 
4. Discussion and conclusion 
4.1 Discussion 
Study results support the effectiveness of a case management intervention in 
reducing HbA1c in one hospital outpatient setting in China. Although recent (2006 
and 2010) meta-analyses in the literature support case management [20, 21], this 
approach in the care of adult diabetics is introduced in a review in 2013 in China 
[22]. Although several reports were published about case management in China 
in the nearly two years, these studies were different from ours: the duration of 
the intervention was shorter and the outcome measures were different, and 
behavior change was not the focus [23, 24]. Therefore, the current study extends 
the literature on case management in China by taking a longer-term, more 
comprehensive approach to providing information and skills, and helping adults 
enhance their own innate ability to attain their diabetes goals. 
Diabetes educators in China were used to using a “teach to” and “I know the 
right thing for you” approach which were found to be generally ineffective [11]. 
The case management approach developed for the current study was adapted to 
Chinese contexts. We set goals with the patients (not for the patients), referred to 
the Chinese guidelines when setting up the education portion and metabolic 
control targets for patients, and aligned the intervention with habits (diet, 
exercise) of Chinese people. 
Interventions implemented at our setting are feasible largely because the 
diabetes education clinics are well established in our hospital and the clinics are a 
frequent site for a variety of research studies. When tested at the onset of the 
study, we found this study’s protocol to be feasible. It is likely that the 
individualized approach used in this study was easier for participants to accept. 
Using blood glucose testing data to adjust diet, exercise, and medication taking 
was important and well-received by participants. 
In the current study, the reduction of HbA1c in the CM group compared with the 
control group was significant at 6 months, with trends observed at 12 months and 24 
months. These results agree with studies in other countries that found an improvement 
in HbA1c after case management interventions [20,21,25]. The reduction of HbA1c 
after case management over a 24-month period in the current study is similar to recent 
findings of Hsu et al. [25], although those authors provided the intervention for a 
longer time, over a 36-month period. 
Recent clinical guidelines support lowering HbA1c to 7% or less to reduce 
microvascular complications of diabetes [12]. At the 24-month time point, the 
percentage of the participants whose HbA1c was < 7.0% was significantly higher in 
the CM group than in the control group, indicating a clinically meaningful finding  
of more successful glycemic control in the CM group at the end of the study.  
The current study demonstrated that case management led to significant 
improvements in the secondary outcomes. Participants’ total self-care behaviors and 
also diet, exercise, blood glucose testing, and foot care were significantly improved 
in the CM group vs. the control group at 12 months. These findings agree with Shin et 
al. [26], and Chang et al. [27] who reported positive self-care behavior changes 1 year 
after case management.  
Given the large numbers of patients seen by the Chinese health care system each 
day, it is imperative that diabetic adults (a) have the appropriate skill set to manage 
psychosocial adjustments related to problems caused by diabetes, and (b) have 
support to help them adjust daily to their diabetes within their lifestyle and 
environmental situation. Based on the Empowerment measure, participants in CM 
group reported that they were able to turn diabetes goals into a workable plan 
and could try out different ways to overcome barriers to attain diabetes goals, 
compared with the control group. Higher empowerment ability is desirable 
because, in that case, patients had an enhanced capacity to accept responsibility for 
their behavior change. Moreover, empowerment ability has been found in the 
literature to be a significant predictor of self-care behavior and HbA1c [28].  
The study has several limitations. First, this study was conducted at one hospital in 
China and lacked blinding. Second, this study did not analyze health care cost, 
because of incomplete data. Third, due to time factors, we did not measure 
participants’ self-care behavior and empowerment ability at 24 months. Finally, just 
the mere action of asking questions could be interpreted as a mild intervention in 
itself, as it might have raised patients’ awareness of topics that were important. 
This could be a factor which might account for changes observed in the control 
group. A strength of the current study is the lack of attrition during the follow-up 
period. Another strength is the study’s feasibility. Finally the CM intervention may 
have been successful because of its intense focusing on the participant, and on the 
individualization of care. 
4.2 Conclusion 
The case management intervention in China was effective at 6 months and, based 
on trends in HbA1c at 12 and 24 months and results in self-care behavior, shows 
promise and warrants more research. This study provides valuable information to 
guide diabetes educators in using case management to promote better control of 
HbA1c and self-behavior change for people with Type 2 diabetes. 
4.3 Practice implications 
In China currently, doctors do not have enough time to educate people with 
diabetes. The diabetes educator, using a case management approach, can help 
overcome this limitation. Due to the high prevalence of Type 2 diabetes and 
prediabetes in China and the low numbers of certified diabetes educators, there is a 
great need for future research on what timing and length of program are most 
effective. Case management may lead to improved quality of care, but quality 
processes and outcomes must be studied. Attention must be focused on the 
sustainability of the effects of case management over time. Due to the labor intensity 
of a 1-year CM intervention and the need for many patients to be seen by the diabetes 
educators, perhaps a shorter three-month CM intervention might be considered on a 
long-term basis in the clinic; its clinical effectiveness would need to be determined. 
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Table 1   Demographic characteristics and clinical variables at baseline 
Variable 
CM group 
(n = 55) 
Control group 
(n = 53) 
P  
Gender, n (%)   0.335 
Male 23 (41.8) 28 (52.8)  
Female 32 (58.2) 25 (47.2)  
Diagnosis of hypertension, n (%)   1.000 
Yes 23 (41.8) 22 (41.5)  
No 32 (58.2) 31 (58.5)  
Diagnosis of hyperlipidemia, n (%)   0.409 
Yes 15 (27.3) 19 (35.9)  
No 40 (72.7) 34 (64.1)  
Diabetes medication modalities, n (%)   0.848 
Oral agents 23 (41.8) 21 (39.6)  
Insulin  9 (16.4) 5 (9.4)  
Oral and insulin 19 (34.5) 25 (47.2)  
None 4 (7.3) 2 (3.8)  
Age 58.35 ± 12.34 59.04 ± 10.67 0.756 
Duration of diabetes (years) 7.08 ± 6.95 7.94 ± 5.69 0.482 
BMI (kg/m
2
) 24.49 ± 3.49 24.55 ± 3.24 0.925 
TG (mmol/l) 1.55 ± 1.17 1.71 ± 1.70 0.583 
HDL (mmol/l) 1.27 ± 0.31 1.29 ± 0.47 0.776 
LDL (mmol/l) 2.91 ± 0.93  2.87 ± 0.91 0.841 
SBP (mmHg) 134.53 ± 17.33 130.25 ± 19.66 0.237 
DBP (mmHg) 81.16 ± 8.43 79.10 ± 10.52 0.265 
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Table 2 Comparison of reduction of HbA1c from baseline between the groups 
Variable 
CM group (n = 55) 
Mean ± SD 
Control group (n = 53) 
Mean ± SD 
Group Difference 
(95% CI)* 
P  
6 months, % -0.55 ± 1.34 0.06 ± 1.44 -0.43 (-0.83, -0.03) 0.034 
12 months, % -0.71 ± 1.23 -0.20 ± 1.40 -0.32 (-0.70, 0.06) 0.094 
24 months, % -0.59 ± 1.70 -0.08 ± 1.44 -0.32 (-0.79, 0.14) 0.167 
*Adjusted baseline HbA1c, group, time, group x time   
 
  Case Management in Adult Diabetics in China  3 
 
Table 3 Self-care behavior between the groups 
Item  
CM group (n = 55) 
Mean ± SD 
  Control group（n = 53） 
Mean ± SD 
 Group Difference 
(95% CI) 
P  
Baseline  12m  Baseline 12m    
Total score 48.89 ± 16.55 58.58 ± 8.62**  44.69 ± 14.68 45.98 ± 18.22  8.40 (4.28, 12.52) <0.001 
Diet 18.87 ± 7.16 22.72 ± 4.56
**
  19.14 ± 7.34 19.36 ± 8.45  1.54 (-0.38, 3.46) 0.114 
Exercise 10.31 ± 4.72 12.45 ± 2.26
**
  8.42 ± 4.92 9.30 ± 4.74  2.52 (1.35, 3.70) <0.001 
Blood glucose 
testing 
4.07 ± 4.04 3.57 ± 2.92 
 
2.26 ± 2.15 1.20 ± 1.11
**
 
 
2.09 (1.22, 2.96) <0.001 
Foot care 9.00 ± 5.61 13.17 ± 2.68
**
  7.72 ± 6.05 9.28 ± 5.03
*
  2.58 (1.21, 3.96) <0.001 
Medication taking 5.87 ± 2.53 6.68 ± 1.24
*
  6.26 ± 1.93 5.92 ± 2.45  0.18 (-0.39, 0.76) 0.528 
* 
within-group comparison，P < 0.05 
** 
within-group comparison，P < 0.01 
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Table 4 Empowerment ability between the groups 
* 
within-group comparison，P < 0.05 
** 
within-group comparison，P < 0.01 
 
 
 
 
Item 
CM group (n = 55) 
Mean ± SD 
 Control group (n = 53) 
Mean ± SD 
 Difference 
(95% CI) 
P 
Baseline  12months   Baseline 12 months     
Total score 34.72 ± 4.10 36.85 ± 2.94
**
   33.96 ± 4.18 35.33 ± 3.07
**
   1.14 (0.14, 2.14) 0.025 
Know what part(s) of taking care of my 
diabetes that I am dissatisfied with 
4.26 ± 0.73 4.72 ± 0.50
**
   4.12 ± 0.88 4.49 ± 0.55
**
   0.18 (-0.005, 0.37) 0.057 
Be able to turn my diabetes goals into a 
workable plan 
4.33 ± 0.78 4.42 ± 0.69   4.04 ± 0.82 4.10 ± 0.65   0.30 (0.10, 0.51) 0.004 
Can try out different ways of 
overcoming barriers to my diabetes 
goals 
4.31 ± 0.72 4.45 ± 0.72  
 
4.10 ± 0.77 4.18 ± 0.60  
 
0.24 (0.05, 0.44) 0.016 
Can find ways to feel better about 
having diabetes 
4.33 ± 0.85 4.57 ± 0.50   4.33 ± 0.80 4.31 ± 0.68   0.13 (-0.07, 0.33) 0.187 
Know the positive ways I cope with 
diabetes-related stress 
4.02 ± 0.91 4.42 ± 0.57
**
   4.16 ± 0.75 4.31 ± 0.59   -0.02 (-0.22, 0.18) 0.860 
Can ask for support for having and 
caring for my diabetes when I need it 
4.46 ± 0.61 4.75 ± 0.43
**
   4.43 ± 0.71 4.55 ± 0.54   0.12 (-0.04, 0.28) 0.143 
Know what helps me stay motivated to 
care for my diabetes 
4.62 ± 0.53 4.79 ± 0.50   4.55 ± 0.68 4.76 ± 0.43
*
   0.05 (-0.09, 0.20) 0.473 
Know enough about myself as a person 
to make diabetes care choices that are 
right for me 
4.37 ± 0.73 4.75 ± 0.43
**
  
 
4.59 ± 0.61 4.63 ± 0.49  
 
-0.05 (-0.21, 0.11) 0.541 
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Fig. 1 Process of behavior change used for participants in the case management group in the first 12 
months 
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Fig. 2 CONSORT flow diagram 
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Analysis 
Figure
Fig. 3 Mean HbA1c for the intervention (CM) and control groups at each study time period
No statistical significance between the two groups through 24 months (P = 0.605) and interaction
of group x time (P = 0.1609). Significant time effect between two groups (P = 0.0007).
Figure
